TP53 and myelodysplastic syndrome: A number of gene mutations and cytogenetic changes have been implicated in the pathogenesis of MDS, including mutations in RAS, TP53, and RUNX1. However, mutations in these genes do not fully explain the pathogenesis of MDS as these mutations are also commonly found in other myeloid malignancies.